Previous Close | 7.74 |
Open | 7.82 |
Bid | 7.94 x 500 |
Ask | 7.97 x 100 |
Day's Range | 7.74 - 8.03 |
52 Week Range | 4.13 - 14.10 |
Volume | |
Avg. Volume | 628,598 |
Market Cap | 185.798M |
Beta (5Y Monthly) | 1.03 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -4.42 |
Earnings Date | May 02, 2024 - May 06, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 6.50 |
Subscribe to Yahoo Finance Plus to view Fair Value for INGN
GOLETA, Calif., March 25, 2024--Inogen To Present at 23rd Annual Needham Virtual Healthcare Conference
GOLETA, Calif., March 07, 2024--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that, effective March 4, 2024, the Compensation Committee of Inogen’s Board of Directors approved awards of restricted stock units as material inducement to Michael Bourque entering into employment with the company to serve as its Executive Vice President, Chief Financial Officer and Treasurer. The equity awards were a
Inogen ( NASDAQ:INGN ) Full Year 2023 Results Key Financial Results Revenue: US$315.7m (down 16% from FY 2022). Net...